Bruker Corp: Form 10-Q for the period ended Jun 30, 2021
Filed with the SEC on Aug 5, 2021 and accepted by EDGAR at Aug 5, 2021, 09:14 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-04-01 to 2021-06-30 | $570.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2021-01-01 to 2021-06-30 | $1.13bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-04-01 to 2021-06-30 | $290.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2021-01-01 to 2021-06-30 | $566.2m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2021-04-01 to 2021-06-30 | $280.6m | us-gaap:GrossProfit |
| Gross profit | 6 months2021-01-01 to 2021-06-30 | $559.3m | us-gaap:GrossProfit |
| Research and development | 3 months2021-04-01 to 2021-06-30 | $55.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2021-01-01 to 2021-06-30 | $110.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2021-04-01 to 2021-06-30 | $134.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2021-01-01 to 2021-06-30 | $266.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-04-01 to 2021-06-30 | $85.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2021-01-01 to 2021-06-30 | $174.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2021-04-01 to 2021-06-30 | $21.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2021-01-01 to 2021-06-30 | $48.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-04-01 to 2021-06-30 | $57.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months2021-01-01 to 2021-06-30 | $114.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-04-01 to 2021-06-30 | $0.38 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2021-01-01 to 2021-06-30 | $0.75 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-04-01 to 2021-06-30 | $0.38 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2021-01-01 to 2021-06-30 | $0.75 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-04-01 to 2021-06-30 | 152,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2021-01-01 to 2021-06-30 | 153,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2021-01-01 to 2021-06-30 | $119.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2021-01-01 to 2021-06-30 | $47.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2021-01-01 to 2021-06-30 | $12.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2021-01-01 to 2021-06-30 | $71.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-06-30 | $608.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-06-30 | $1.97bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-06-30 | $3.09bn | us-gaap:Assets |
| Current liabilities | At period end2021-06-30 | $954.6m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2021-06-30 | $721.1m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2021-06-30 | $1.00bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-21-237150. Last ingested by Listed: Nov 5, 2026, 16:58 ET. Listed shows no prices and gives no investment advice.